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the prevalence rate of HBsAg, 226 blood samples were screened by
parallel diagnostic method using One Step Strip Style HBsAg test
kits. The percentage prevalence of HBV infection was calculated
by using patients with positive samples as numerator and the total
numbers of the voluntary blood donor among the population of the
studyareaasdenominator. Thedatagenerated fromthis studywere
presented using descriptive statistics and chi-square to determine
any signiﬁcant relationship infection rate, age and gender.
Results: The overall prevalence rate of HBsAg of 8.9% was
recorded. Age group (20-29) years had the highest prevalence of
HBsAg (4%) compared to (3.1%) of the age group (10-19) years and
(1.8%) of age group (30-39) years. HBsAg seropositivity was more
prevalent among males (10.5%) than their female counterparts
(9.26%). Age and Sex were statistically signiﬁcant (p-value<0.05)
by Chi-square test. This study conﬁrmed that HBsAg is prevalent
among screened asymptomatic healthy and sexually active youths
in Ishiagu community
Conclusion: Hence, general surveillance, mass immunization
and public health education to stop the spread of the infection
among general populace in Ishiagu community in Ivo Local Gov-
ernment of Ebonyi State is advocated. General surveillance through
mass screening to identify those with infection and instituting
appropriate treatments,mass immunization of the uninfected pop-
ulation against the virus and public health education to enlighten
blood donors in entire Ishiagu Community of the possible risk fac-
tors and routes of infection are indeed advocated.
http://dx.doi.org/10.1016/j.ijid.2016.02.955
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Background: The HBV- x gene expresses a 154 aminoacid
multifunctional protein widely associated with hepatocellular car-
cinoma in chronic patients. Genetic variability of the x gene may
impact the differential oncogenic potential of HBV genotypes. This
study attempts to investigate genetic variability of the HBV x gene
in patients with chronic hepatitis B (CHBV) infection at a tertiary
care hospital in Kerala, South India.
Methods & Materials: Blood samples from ﬁfteen CHBV
patients attending the gastroenterology unit of Pushpagiri Insti-
tute of Medical Science and Research Centre (PIMS & RC) were
included. All samples were tested for HBsAg, HBeAg, HBc IgM, Anti
HBs titre and biochemical tests {Aspartate transaminase (AST) &
Alanine transaminase (ALT)}. All samples were screened by nested
PCR, using primers targeting the core gene of HBV genome. HBV x
gene was ampliﬁed using previously published primers and ana-
lysed by sequencing. All sequencing data were assembled, aligned
and compared to the consensus HBV sequence to detect the muta-
tions. Phylogenetic and mutation analyses were done using MEGA
version 6.0.
Results: Of the 15 samples thatwere positive for HBV core gene,
the HBV x gene was detected in 11 (73%) samples while four were
negative. Majority of patients were infected with genotypes A (6,
54%) followed by D (5, 45%). All genotypes A strains belonged to
subgenotype A1. The A1762T/G1764A double mutation in the BCP
region, signiﬁcantly related to HCC in earlier reported studies was
found in 4 patients. Patients with genotype A1 had 50% risk of har-
bouring the 1762/1764 double mutation. The mutation C1485T in
the x gene region were found in 10 samples. The mutation G1467A
were observed in all patients with genotype A1.
Conclusion: A1 was the predominant subgenotype seen in this
study. Mutations were signiﬁcantly high in A1 strains. Association
of these mutations with HCC/cirrhosis is unknown. Larger studies
areessential forbetterunderstandingof the roleof thesemutations.
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Background: HBV causes 780,000 deaths yearly worldwide. It’s
endemic in Africa and of the ten known genotypes (A-J), A,D and
E are prominent in Africa. Kenya is geographically located at the
junction of these three genotypes and there is a paucity of HBV
genotyping data.
This study investigated molecular characterization of HBV cir-
culating among outpatients of selected hospitals in Kenya.
Methods & Materials: 332 serum samples were obtained from
patients with jaundice seeking medical services in four selected
hospitals in Kenya. Hepatitis B surface Antigen and Antibody to
the core antigen (HBsAg and HBcAb) were tested using commer-
cial EIA (Elecsys, Roche Diagnostics). The HBsAg coding region was
ampliﬁed and sequenced in all HBV DNA positive samples, with 20
specimens chosen at random for full genome sequence analysis.
Results: HBsAg positivity was 50.6% (168/332) with 66.9%
showing DNA positivity among samples having sufﬁcient volume
for DNA testing (93/139). 2.0% were anti-HBc IgM positive, indicat-
ing acute infection Based on HBsAg region sequencing, genotype A
was predominant (90.3%), followed by genotype D (9.7%). HBV/D-
infected individuals had a mean age of 43.0±2.0 years whereas
HBV/A-infected individuals had a mean age of 34.0±4.0 years
(Fisher test, p=0.02). Nucleotide distance measurements of the 20
full genome HBV/D sequences demonstrated two isolates having
